Consistent improvement with eculizumab across muscle groups in myasthenia gravis

by Renato Mantegazza, Fanny L. O'Brien, Marcus Yountz, James F. Howard Jr, for the REGAIN study group
Published 2020-08-01

Long‐term efficacy of eculizumab in refractory generalized myasthenia gravis: responder analyses

by James F. Howard Jr, Chafic Karam, Marcus Yountz, Fanny L. O’Brien, Tahseen Mozaffar, for the REGAIN Study Group
Published 2021-07-01